Related Experiment Video
Updated: Feb 8, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Proteomic profile of patients with atrial fibrillation undergoing cardiac surgery
Ilias P Doulamis1, George Samanidis2, Aspasia Tzani1
1Laboratory for Experimental Surgery and Surgical Research "N.S Christeas", Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Insights
Growth/differentiation factor 15 and resistin show promise as biomarkers for atrial fibrillation (AF) risk in cardiovascular disease patients. Further proteomic research is needed to confirm their role and explore underlying molecular pathways.
Area of Science:
- Cardiovascular Medicine
- Proteomics
- Biomarker Discovery
Background:
- Atrial fibrillation (AF) is a common complication in patients with cardiovascular disease.
- Identifying reliable biomarkers for AF risk stratification is crucial for patient management.
Purpose of the Study:
- To identify potential proteomic biomarkers for atrial fibrillation (AF) in patients with advanced cardiovascular disease.
- To evaluate the predictive capacity of serum protein levels for AF.
Main Methods:
- Proteomic analysis of serum samples from 123 cardiac surgery patients (22 with AF, 101 without AF) and 20 healthy controls.
- Measurement of 22 specific proteins, including growth/differentiation factor 15 and resistin.
- Statistical analysis using linear models and Matthews Correlation Coefficient; combined markers assessed with Support Vector Machines.
Main Results:
- Serum levels of most measured proteins were higher in cardiovascular disease patients than in healthy subjects.
- Growth/differentiation factor 15 and resistin were significantly elevated in patients with AF compared to those without AF (P=0.029 and P=0.007, respectively).
- Certain biomarker pairs demonstrated moderate predictive capability for AF.
Conclusions:
- Growth/differentiation factor 15 and resistin may aid in stratifying AF risk among cardiovascular disease patients.
- Further proteomic research and investigation into molecular pathways are warranted to validate these findings.
Objectives:
Proteomic analysis of patients with advanced cardiovascular disease was conducted to identify possible biomarkers for atrial fibrillation (AF).
Methods:
A total of 123 patients undergoing cardiac surgery (22 with AF and 101 without AF) and 20 healthy subjects were recruited. Demographic data, patient history and blood samples were collected. Growth/differentiation factor 15, resistin, intracellular adhesion molecule-1, galectin-3, trefoil factor 3, tissue inhibitor of metalloproteinases 1, matrix metallopeptidase 9, high-sensitive troponin T, interleukins 6, 1α, 3, 4, 8, 20 and 22, tumour necrosis factor alpha, C-X-C motif chemokines 10 and 11, S100A6 and Type III procollagen were measured in blood serum. Differential expression between any 2 groups for any of the measured proteins was identified by fitting linear models, whereas Matthews Correlation Coefficient was used to evaluate their predictive capacity. Combined markers using more than 1 protein were attained via weighted Support Vector Machines.
Results:
Although serum levels of the markers were higher in patients with cardiovascular disease than in healthy subjects, only growth/differentiation factor 15 and resistin were significantly higher in patients with AF among the subpopulation who underwent heart surgery (P = 0.029 and P = 0.007, respectively). Specific pairs of several biomarkers had mediocre predictive capacity for AF.
Conclusions:
Growth/differentiation factor 15 and resistin are 2 markers that could be helpful in stratifying risk for AF in patients with cardiovascular disease. Yet, more research in terms of proteomics and investigation of possible molecular pathways implicated is required.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...

